ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023
January 08, 2024 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, Jan. 08, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023
November 13, 2023 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, Nov. 13, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023
November 07, 2023 12:15 ET
|
ImmuCell Corporation
PORTLAND, Maine, Nov. 07, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023
October 05, 2023 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, Oct. 05, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Submission of CMC Technical Section to the FDA
August 29, 2023 08:00 ET
|
ImmuCell Corporation
PORTLAND, Maine, Aug. 29, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023
August 10, 2023 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, Aug. 10, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023
August 07, 2023 12:00 ET
|
ImmuCell Corporation
PORTLAND, Maine, Aug. 07, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023
July 11, 2023 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, July 11, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Change in Timing of Anticipated FDA Submission
June 28, 2023 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, June 28, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Appoints Bryan K. Gathagan to Board of Directors
June 21, 2023 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, June 21, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...